GUANGXI WUZHOU ZHONGHENG GROUP CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.25 CNY | +0.45% |
|
+0.90% | -10.36% |
| Sales 2022 | 2.71B 375M | Sales 2023 | 3.1B 427M | Capitalization | 8.65B 1.19B |
|---|---|---|---|---|---|
| Net income 2022 | 79M 10.91M | Net income 2023 | 84M 11.6M | EV / Sales 2022 | 2.53 x |
| Net cash position 2022 | 2.24B 309M | Net cash position 2023 | 2.3B 318M | EV / Sales 2023 | 2.05 x |
| P/E ratio 2022 |
114
x | P/E ratio 2023 |
102
x | Employees | 2,886 |
| Yield 2022 |
0.38% | Yield 2023 |
0.4% | Free-Float | 67.38% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.45% | ||
| 1 week | +0.90% | ||
| Current month | -1.75% | ||
| 1 month | -2.17% | ||
| 3 months | +2.74% | ||
| 6 months | -13.13% | ||
| Current year | -10.36% |
1 week
2.22
2.27
1 month
2.192.35
Current year
1.902.58
1 year
1.902.79
3 years
1.904.25
5 years
1.904.25
10 years
1.9010.67
| Managers | Title | Age | Since |
|---|---|---|---|
Yi Dong Ni
CEO | Chief Executive Officer | 53 | 22-07-28 |
Wan Wei Yi
DFI | Director of Finance/CFO | 41 | 19-12-26 |
Kun Shi Wang
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Ming Liang Liu
CHM | Chairman | 73 | 06-12-29 |
Zhong Jun Li
BRD | Director/Board Member | 60 | 20-01-12 |
Hong Liang Wang
BRD | Director/Board Member | 51 | 20-01-12 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.38% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-22 | 2.25 | +0.45% | 24 433 950 |
| 24-04-22 | 2.24 | +0.45% | 27,055,500 |
| 24-04-19 | 2.23 | -0.45% | 26,421,700 |
| 24-04-18 | 2.24 | -1.32% | 35,661,670 |
| 24-04-17 | 2.27 | +2.71% | 38,859,720 |
End-of-day quote Shanghai S.E., April 22, 2024
More quotes
GUANGXI WUZHOU ZHONGHENG GROUP CO., LTD is a China-based company, principally engaged in the manufacture of pharmaceuticals and food production. The Company's pharmaceuticals include cardiovascular drugs, medicine for bruises, gynecology medication and other general drugs. The Company also provides Chinese herbal jelly products, Chinese herbal beverages and others. The Company is also engaged in the development of real estate, including the development and sales of commercial housings and stores. The Company mainly conducts its businesses within domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-04-29
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -10.36% | 1.07B | |
| +27.17% | 659B | |
| +27.68% | 557B | |
| -4.75% | 359B | |
| +16.88% | 322B | |
| +9.66% | 297B | |
| +6.17% | 215B | |
| +5.37% | 210B | |
| -6.01% | 200B | |
| -8.37% | 149B |
- Stock Market
- Equities
- 600252 Stock
